Safely Optimizing Body Weight with TCMCB07 in Patients with Newly Diagnosed Metastatic Colorectal Cancer Undergoing Chemotherapy
- Sponsor:
- Endevica Bio
- Sponsor Study ID:
- TCMCB07-01
- CTO #:
- 104290
- NCT Number:
- NCT06937177
- Phase:
- II
- Protocol Type:
- Supportive Care
- Age Group:
- Adults
- Disease Sites:
- Colon
- Study Objectives:
- To evaluate the effect of B07 relative to placebo on body weight over 12 weeks in newly diagnosed metastatic colorectal cancer patients. To evaluate the safety of B07 relative to placebo through Week 12.
- eConsent:
- Not available
- Study Documents:
-
Open Study Documents
(MUSC NetID required for document access)
For more information about this trial please contact the study team:
-
Medical University of South Carolina
- Principal Investigator, Guttridge, Denis, at guttridg@musc.edu
- Study Coordinator, Wagner, Marissa, at wagnemar@musc.edu
Trial opened at the following institutions:
Medical University of South Carolina